Search research articles
Contact Us
Filters
Showing results (701-710 of 735) with videos related to
Page
of 74
Sort By:
Expert Review of Vaccines
|
June 1, 2021
Immunogenicity and safety of a high-dose and prolonged-schedule hepatitis B vaccine among chronic kidney disease patients: a randomized, parallel-controlled trial
Yongliang Feng, Tian Yao, Yujie Han, et al.
China CDC Weekly
|
December 30, 2024
Immunogenicity of Short-Course, High-Dose Hepatitis B Vaccination in Patients with Chronic Kidney Disease - Shanxi Province, China, 2019-2020
Linying Gao, Xufeng Cui, Xinyuan Mo, et al.
Frontiers in Cardiovascular Medicine
|
June 1, 2022
Long Short-Term Memory Network for Development and Simulation of Warfarin Dosing Model Based on Time Series Anticoagulant Data
Yun Kuang, Yaxin Liu, Qi Pei, et al.
Journal of Pharmaceutical Sciences
|
August 27, 2015
Comprehensive Analysis of the Therapeutic IgG4 Antibody Pembrolizumab: Hinge Modification Blocks Half Molecule Exchange In Vitro and In Vivo
Xiaoyu Yang, Fengqiang Wang, Ying Zhang, et al.
British Journal of Neurosurgery
|
April 3, 2020
Comparison of complications in cranioplasty with various materials: a systematic review and meta-analysis
Liming Liu, Shou-Tao Lu, Ai-Hua Liu, et al.
Frontiers in Immunology
|
August 28, 2025
Clonal divergence and genomic meltdown in prostatic pleomorphic giant cell adenocarcinoma
Xiaoshi Ma, Kun Chen, Jing Zhang, et al.
Viruses
|
December 23, 2023
Identification of Mudanjiang Phlebovirus in the Daxing'anling Region of China
Chenli Fang, Yantao Liu, Fang Tang, et al.
Nature Communications
|
July 9, 2024
Unlocking the function promiscuity of old yellow enzyme to catalyze asymmetric Morita-Baylis-Hillman reaction
Lei Wang, Yaoyun Wu, Jun Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 2015
A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
Elena Gabriela Chiorean, Patricia LoRusso, Robert Matthew Strother, et al.
Expert Review of Vaccines
|
August 15, 2022
Duration of immunogenicity of high-dose and prolonged-schedule hepatitis B vaccine among patients with chronic kidney disease: A one year follow-up study in China
Yujie Han, Na Cao, Xiaoxiao Lu, et al.
Page
of 74
Search research articles
Search
Showing results (701-710 of 735) with videos related to
Sort By:
Page
of 74
Expert Review of Vaccines
|
June 1, 2021
Immunogenicity and safety of a high-dose and prolonged-schedule hepatitis B vaccine among chronic kidney disease patients: a randomized, parallel-controlled trial
Yongliang Feng, Tian Yao, Yujie Han, et al.
China CDC Weekly
|
December 30, 2024
Immunogenicity of Short-Course, High-Dose Hepatitis B Vaccination in Patients with Chronic Kidney Disease - Shanxi Province, China, 2019-2020
Linying Gao, Xufeng Cui, Xinyuan Mo, et al.
Frontiers in Cardiovascular Medicine
|
June 1, 2022
Long Short-Term Memory Network for Development and Simulation of Warfarin Dosing Model Based on Time Series Anticoagulant Data
Yun Kuang, Yaxin Liu, Qi Pei, et al.
Journal of Pharmaceutical Sciences
|
August 27, 2015
Comprehensive Analysis of the Therapeutic IgG4 Antibody Pembrolizumab: Hinge Modification Blocks Half Molecule Exchange In Vitro and In Vivo
Xiaoyu Yang, Fengqiang Wang, Ying Zhang, et al.
British Journal of Neurosurgery
|
April 3, 2020
Comparison of complications in cranioplasty with various materials: a systematic review and meta-analysis
Liming Liu, Shou-Tao Lu, Ai-Hua Liu, et al.
Frontiers in Immunology
|
August 28, 2025
Clonal divergence and genomic meltdown in prostatic pleomorphic giant cell adenocarcinoma
Xiaoshi Ma, Kun Chen, Jing Zhang, et al.
Viruses
|
December 23, 2023
Identification of Mudanjiang Phlebovirus in the Daxing'anling Region of China
Chenli Fang, Yantao Liu, Fang Tang, et al.
Nature Communications
|
July 9, 2024
Unlocking the function promiscuity of old yellow enzyme to catalyze asymmetric Morita-Baylis-Hillman reaction
Lei Wang, Yaoyun Wu, Jun Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 2015
A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
Elena Gabriela Chiorean, Patricia LoRusso, Robert Matthew Strother, et al.
Expert Review of Vaccines
|
August 15, 2022
Duration of immunogenicity of high-dose and prolonged-schedule hepatitis B vaccine among patients with chronic kidney disease: A one year follow-up study in China
Yujie Han, Na Cao, Xiaoxiao Lu, et al.
Page
of 74